Accuracy of various human NAT2 SNP genotyping panels to infer rapid, intermediate and slow acetylator phenotypes.
about
Arylamine N-acetyltransferases: from drug metabolism and pharmacogenetics to drug discoveryPharmGKB summary: very important pharmacogene information for N-acetyltransferase 2Pharmacogenetics of treatment response in psoriatic arthritisExploring the relationship between lifestyles, diets and genetic adaptations in humansMulticenter study of trimethoprim/sulfamethoxazole-related hepatotoxicity: incidence and associated factors among HIV-infected patients treated for Pneumocystis jirovecii pneumoniaThe Non-Linear Child: Ontogeny, Isoniazid Concentration, and NAT2 Genotype Modulate Enzyme Reaction Kinetics and MetabolismPolymorphic genes of detoxification and mitochondrial enzymes and risk for progressive supranuclear palsy: a case control study.NAT1 and NAT2 genetic polymorphisms and environmental exposure as risk factors for oesophageal squamous cell carcinoma: a case-control studyIdentification and validation of N-acetyltransferase 2 as an insulin sensitivity genePharmacogenetic allele nomenclature: International workgroup recommendations for test result reporting.Polymorphisms in carcinogen metabolism enzymes, fish intake, and risk of prostate cancerSmoking, variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2), and risk of non-Hodgkin lymphoma: a pooled analysis within the InterLymph consortium.Optimization of Clonazepam Therapy Adjusted to Patient's CYP3A Status and NAT2 Genotype.Novel NAT2 haplotyping using allele-specific sequencing.Evaluation of the Adequacy of the 2010 Revised World Health Organization Recommended Dosages of the First-line Antituberculosis Drugs for Children.Population Pharmacokinetics/Pharmacodynamics of 3,4-Diaminopyridine Free Base in Patients With Lambert-Eaton MyastheniaPharmacogenetics and pharmacogenomics in psoriasis treatment: current challenges and future prospects.Pharmacogenomics of multifactorial diseases: a focus on psoriatic arthritis.NAT2 genetic variations among South Indian populations.Gene-diet interactions in exposure to heterocyclic aromatic amines and bulky DNA adduct levels in blood leukocytes.Improved genotyping of N-acetyltransferase 2: role of the ultra-slow acetylators.N-acetyltransferase 1 and 2 polymorphisms and risk of diabetes mellitus type 2 in a Saudi population.Heritability of Caffeine Metabolism: Environmental Effects Masking Genetic Effects on CYP1A2 Activity but Not on NAT2.Arylamine N-acetyltransferase 2 genotype-dependent N-acetylation of isoniazid in cryopreserved human hepatocytes.Association of NAT2 polymorphisms with risk of colorectal adenomas: Evidence from 3,197 cases and 4,681 controls.Lack of association between NAT2 polymorphism and prostate cancer risk: a meta-analysis and trial sequential analysisAssociation and clinical utility of NAT2 in the prediction of isoniazid-induced liver injury in Singaporean patients.Determination of NAT2 acetylation status in the Greenlandic population.Refinement of the prediction of N-acetyltransferase 2 (NAT2) phenotypes with respect to enzyme activity and urinary bladder cancer risk.Coffee and tea consumption, genotype-based CYP1A2 and NAT2 activity and colorectal cancer risk-results from the EPIC cohort study.NAT2 sequence polymorphisms and acetylation profiles in Indians.Sequence analysis of the N-acetyltransferase 2 gene (NAT2) among Jordanian volunteers.Role of N-acetyltransferase 2 acetylation polymorphism in 4, 4'-methylene bis (2-chloroaniline) biotransformation.Genetic heterogeneity among slow acetylator N-acetyltransferase 2 phenotypes in cryopreserved human hepatocytes.Association between the PINX1 and NAT2 polymorphisms and serum lipid levels.Rapid identification of the NAT2 genotype in tuberculosis patients by multicolor melting curve analysis.Expression of NAT2 in immune system cells and the relation of NAT2 gene polymorphisms in the anti-tuberculosis therapy in Mexican mestizo population.Effect of Genetic Variation of NAT2 on Isoniazid and SLCO1B1 and CES2 on Rifampin Pharmacokinetics in Ghanaian Children with Tuberculosis.Role of the N-acetylation polymorphism in solithromycin metabolism.N-Acetyltransferase-2 (NAT2) phenotype is influenced by genotype-environment interaction in Ethiopians.
P2860
Q26995125-95C3D83C-D605-4DB3-960D-BDC208D4209CQ27011622-31210B81-76C9-4AE8-90E4-620A3213B9CEQ28081252-DF94490F-1EB8-4503-9436-2298891A338AQ28262492-B6738508-B092-4AF8-8E3A-5E1A6B6A5C13Q28542714-B44EA275-2ABD-4B40-BACF-8E91F5902C36Q28822540-08B909C9-BEA8-448B-8A6A-BCA1ECF1864DQ34198178-E1665F88-4DEB-44E3-9E51-F37A1FF9A640Q35233775-42CF5356-D517-4214-90B0-319894972C63Q35535617-9B260BBA-5EAA-4939-8276-F2C097C41CA3Q35812195-6EA0F2DD-C4A7-4580-BD9F-706AC4763D12Q36401990-7E64C2AC-E50F-45B4-B348-960BA5FE66FDQ36487605-3BF83C9F-5473-4794-8B83-F4C0544E0FF3Q37547290-7D2D681E-EE0A-4465-87DD-C5D3F4775DFBQ38435618-D8197659-B188-4288-9687-62B66F93C2B0Q38673843-5CF42263-7C67-45E4-A3BA-79F57AC7B1FCQ38721390-AF4AFEDD-B246-4908-ACCB-F705C45ABB99Q38856372-863E5018-A595-4276-8CED-E7B319C434A2Q38857254-EBF8FD85-582D-4695-93FA-C2BDCDFEB6CBQ38893783-19CB2713-02E8-42CF-90B4-3DBEF2788D76Q39002775-85834BE9-69A3-44D8-A5B4-082E4D6B2B9BQ39336687-CB8C7EFE-ECBD-4D2C-902A-4D6848F482E9Q40497358-32D0E5B8-57C5-4B72-9F65-D3FAFF02883CQ40628246-16D59E62-45E9-41D9-AB5E-E1D73D6C0B06Q41068782-5CFEB7EC-FE13-4ECE-9F65-469DD353DF8CQ41318734-3C45F824-B632-4F42-B1EE-135A7E7B9DE6Q41341423-5C759821-0668-44DB-9577-CA7B6B5DA7B0Q42696912-3FDD06BD-9DEF-45CB-8EDB-A3A49F460AB4Q42702218-869AF5D4-F16F-4510-80BB-39657B974BC6Q42708451-48FABBF3-F485-4B11-891C-7FDD74EA58F2Q46004843-54D18D3C-8D7B-4AB6-B730-49D4C4C21F91Q46148230-214AC71F-3F04-45D4-A739-1CEFC237E2D6Q46496343-7BD30E06-7A8C-4580-BC93-44404D39E833Q47359205-D925522C-B8F1-4D44-AAB8-BD416FEB7D0DQ48129221-6C0DC1A3-E492-4C9D-9F15-C263D40720C8Q49294719-983406AB-1930-4696-A10D-90658BE9E77BQ51664167-CAEFF31D-258B-4D92-8F8C-0725AA1E4EB8Q51747019-3E9E8798-C5BF-466A-BCA4-D413AFF9D21FQ52742072-661B00DA-839C-4167-84FB-D2046070EB93Q55154837-824FA17B-640A-45FC-8009-90F84E150A2BQ55376625-068B06AC-F94A-4C93-8EBE-569C770E43F4
P2860
Accuracy of various human NAT2 SNP genotyping panels to infer rapid, intermediate and slow acetylator phenotypes.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Accuracy of various human NAT2 ...... nd slow acetylator phenotypes.
@ast
Accuracy of various human NAT2 ...... nd slow acetylator phenotypes.
@en
type
label
Accuracy of various human NAT2 ...... nd slow acetylator phenotypes.
@ast
Accuracy of various human NAT2 ...... nd slow acetylator phenotypes.
@en
prefLabel
Accuracy of various human NAT2 ...... nd slow acetylator phenotypes.
@ast
Accuracy of various human NAT2 ...... nd slow acetylator phenotypes.
@en
P2860
P356
P1433
P1476
Accuracy of various human NAT2 ...... nd slow acetylator phenotypes.
@en
P2093
Mark A Doll
P2860
P356
10.2217/PGS.11.122
P577
2011-11-17T00:00:00Z